Apoptotic cellular events for selenium compounds involved in cancer prevention
- 16 February 2007
- journal article
- Published by Springer Nature in Journal of Bioenergetics and Biomembranes
- Vol. 39 (1) , 91-98
- https://doi.org/10.1007/s10863-006-9065-7
Abstract
Converging data from epidemiological, ecological, and clinical studies have shown that selenium (Se) can decrease the risk for some types of human cancers. Induction of apoptosis is considered an important cellular event that can account for the cancer preventive effects of Se. Prior to occurrence of apoptosis, Se compounds alter the expression and/or activities of signaling molecules, mitochondria-associated factors, transcriptional factors, tumor suppressor genes, and cellular reduced glutathione. Mechanistic studies have demonstrated that the methylselenol metabolite pool has many desirable attributes of chemoprevention, whereas the hydrogen selenide pool with excess of selenoprotein synthesis can lead to DNA single-strand breaks. To elucidate the effects of Se on cytotoxic events, it should be remembered that the chemical forms and the dose of Se, and the experimental system used, are determinants of its biological activities. This mini-review focuses on elucidation of the molecular mechanisms of cancer prevention by Se with the apoptotic approach.Keywords
This publication has 53 references indexed in Scilit:
- Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathwayMolecular Cancer Therapeutics, 2006
- Cancer chemoprevention: Selenium as a prooxidant, not an antioxidantMedical Hypotheses, 2006
- Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosisOncogene, 2005
- PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cellsCarcinogenesis: Integrative Cancer Research, 2005
- Manganese Superoxide Dismutase Polymorphism, Prediagnostic Antioxidant Status, and Risk of Clinical Significant Prostate CancerCancer Research, 2005
- Methylseleninic Acid Potentiates Apoptosis Induced by Chemotherapeutic Drugs in Androgen-Independent Prostate Cancer CellsClinical Cancer Research, 2005
- Selenium and Vitamin E Cancer Prevention TrialAnnals of the New York Academy of Sciences, 2004
- Reactive oxygen species in oncogenic transformationBiochemical Society Transactions, 2003
- SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and designProstate Cancer and Prostatic Diseases, 2000
- Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosisOncogene, 2000